Glaucoma: References

1. Weinreb RN, Khaw PT. Primary open–angle glaucoma. Lancet. 2004;363:1711–1720.
 
2. Leske MC. The epidemiology of open–angle glaucoma: a review. Am J Epidemiol. 1983;118:166–191.

3. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause–specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412–1417.

4. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open–angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369–374.

5. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open– angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994;112:69–73.

6. Hennis A, Wu SY, Nemesure B, Leske MC; Barbados Eye Studies Group. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology. 2003;110:908–914.

7. Nemesure B, Wu SY, Hennis A, Leske MC; Leske MC; Barbados Eye Studies Group. Factors related to the 4–year risk of high intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol. 2003;121:856–862.

8. Distelhorst JS, Hughes GM. Open–angle glaucoma. Am Fam Physician. 2003;67:1937–1944.

9. Puustjarvi T, Blomster H, Kontkanen M, Punnonen K, Terasvirta M. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242:749–754.

10. Leibovitch I, Kurtz S, Shemesh G, et al.  Hyperhomocystinemia in pseudoexfoliation glaucoma. J Glaucoma. 2003;12:36–39.

11. American Academy of Ophthalmology. Preferred Practice Pattern, Primary Open–Angle Glaucoma. American Academy of Ophthalmology, 1996.

12. Girkin CA, McGwin G Jr, McNeal SF, et al. Hypothyroidism and the development of open–angle glaucoma in a male population. Ophthalmology. 2004;111:1649–1652.

13. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224–2228.

14. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–1279.

15. Higginbotham EJ, Gordon MO, Beiser JA, et al. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open–angle glaucoma in African American individuals. Arch Ophthalmol. 2004;122:813–820.

16. Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110:359–362.

17. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953.

18. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954–1965.